Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...

Dr. David A. Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.

Professor Meghan Morrissey earns an innovation award to program immune cells to attack cancer tumors. #immunotherapy ...

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

She is also the chief medical officer of the lab consultancy firm Blood Associates, LLC. Bladder cancer occurs when cancerous cells form in the tissues of the bladder, the hollow organ in your ...

A combination therapy of two drugs — a statin and a protein inhibitor — may help suppress the creation and growth of tumors ...

A recent study finds that sequential gemcitabine/docetaxel treatment offers better outcomes than additional BCG therapy for ...

Objective response rate: The percentage of patients whose cancer shrinks or disappears after treatment. Bacillus Calmette-Guérin (BCG): A type of immunotherapy used to treat bladder cancer by ...

Researchers aim to validate the AI tool SCORPIO in prospective studies and eventually seek FDA clearance to sell it as a commercial tool in the US.

Innovative fluorescence-based diagnostic system identifies early-stage bladder cancer with 90% accuracy, utilizing untreated ...